Symptom management is a vital aspect of the practice of oncology nursing. The Oncology Nursing Society has identifi ed outcomes sensitive to nursing intervention, known as nursing-sensitive patient outcomes. This article presents information about sleep-wake disturbances that occur in patients with cancer and makes recommendations for evidence-based interventions to improve sleep for patients. Sleep-wake disturbances occur in 30%-75% of people with cancer and have a negative impact on other symptoms and quality of life. Despite the frequency and severity of sleep-wake disturbances, limited research has tested interventions to improve sleep-wake outcomes. Although no interventions currently receive the highest recommendations for implementation into practice, several nonpharmacologic interventions show initial positive fi ndings in promoting high-quality sleep and daytime functioning. Oncology nurses can screen for sleep-wake disturbances and suggest tailored interventions. Four categories of promising interventions are cognitive-behavioral therapy, complementary therapies, psychoeducation and information, and exercise. Clinicians can use the Putting Evidence Into Practice (PEP) card and PEP resources at www.ons .org/outcomes to improve sleep-wake outcomes.
C hanges in health policy have mandated cost-effective, high-quality care for which healthcare providers are held accountable. The Oncology Nursing Society (ONS) has identified nursing-sensitive patient outcomes (NSPOs) for patients with cancer. NSPOs are outcomes that are attained through or are signifi cantly impacted by nursing interventions. The interventions must be within the scope of nursing practice and integral to the processes of nursing care (Given & Sherwood, 2005) . The Putting Evidence Into Practice (PEP) weight-of-evidence classifi cation model provides guidance for nursing interventions based on the evidence in each practice area (Gobel, Beck, & O'Leary, 2006) .
Sleep-Wake Disturbances
Cancer and treatment-related symptoms are patient-centered outcomes infl uenced by nursing care (Given & Sherwood, 2005) . In 2004, an ONS state-of-the-science conference about sleepwake disturbances in patients with cancer and their caregivers was held. A group of experts in the fi eld of sleep-wake disturbances in patients with cancer defi ned the outcome, reviewed the literature regarding tools with which it could be measured, and presented current studies on interventions to improve the Nursing-sensitive patient outcomes are outcomes that are attained through or are signifi cantly impacted by nursing interventions. The interventions must be within the scope of nursing practice and integral to the processes of nursing care.
outcome . Sleep-wake disturbances then was added to the list of outcomes to be developed in the PEP project. Sleep-wake disturbances are patient-centered outcomes that can be improved with nursing care. The disturbances are perceived This material is protected by U.S. copyright law. Unauthorized reproduction is prohibited. To purchase quantity reprints, please e-mail reprints@ons.org or to request permission to reproduce multiple copies, please e-mail pubpermissions@ons.org. or actual alterations in the nine parameters or characteristics of sleep, as defi ned in Figure 1 and in .
Sleep-wake disturbances are prevalent in approximately 30%-75% of patients with cancer Lee, Cho, Miaskowski, & Dodd, 2004) . Not only do the disturbances affect adults and children, but they also affect caregivers. Sleep-wake disturbances have been identifi ed in a variety of diagnoses and times related to the cancer experience . Disturbed sleep may occur alone or as part of a symptom cluster. Sleep-wake disturbances have been identifi ed as part of a cluster associated with fatigue, pain, and mood (Miaskowski & Lee, 1999) . Lack of sleep or poor sleep can affect overall quality of life as well as compound other symptoms (Beck, Dudley, & Barsevick, 2005) . If an individual cannot sleep, his or her ability to heal, maintain activities of daily living, continue to work, and maintain family and intimate relationships is affected adversely (Savard & Morin, 2001) .
Symptom management is a key component of oncology nurses' scope of practice. Each nurse has the opportunity to impact the quality of life of his or her patients by being familiar with current literature that supports specifi c practices. This includes evaluating and utilizing the varying treatment modalities that have been studied, reviewed, and/or recommended by experts to treat sleep-wake disturbances. Besides pharmacologic agents, four categories of promising nonpharmacologic interventions for sleep-wake disturbances have been identifi ed: cognitive-behavioral therapies (CBTs), complementary therapies (CTs), psychoeducation and information, and exercise. The categories and the specifi c interventions described in this article are defi ned at www.ons.org/outcomes. Understanding the symptoms and the interventions recommended as well as where to best fi nd the most current information is crucial for providing optimal evidence-based patient care.
Highlights of the Reviewed Literature
At the present time, no nursing intervention can be categorized as "recommended for nursing practice" to assist patients with cancer with sleep-wake disturbances. For an intervention to meet criteria in that ONS PEP weight-of-evidence category, it needs to have demonstrated effectiveness by strong evidence from rigorously designed studies, meta-analyses, or systematic reviews and demonstrate that the risk of harm is small compared with the benefi t. Also, no nursing intervention can be classifi ed as "likely to be effective" at this time. Interventions in that ONS PEP weight-of-evidence category must show evidence that is less well established than would be expected for interventions that meet the criteria to be included in the "recommended for practice" category, such as supportive evidence from a single, well-conducted, randomized, controlled trial that included fewer than 100 subjects. Studies are needed that test pharmacologic and nonpharmacologic interventions in patients with cancer to identify those that meet the rigorous criteria to be listed in those PEP weight-of-evidence categories. See inset for the Sleep Team's PEP process.
Pharmacologic Interventions
Despite widespread use of such interventions, the fi nding that no published meta-analysis or experimental design study has examined the effi cacy of using sedative-hypnotic drugs, such as benzodiazepines, in patients with cancer was surprising. Pharmacologic interventions have been assigned to the ONS PEP weight-of-evidence category "benefi ts balanced with harms," which infers that clinicians and patients should weigh the benefi cial and harmful effects according to individual circumstances and priorities.
Although the drugs have not been studied in patients with cancer, sedative-hypnotics are prescribed commonly for Based on the evidence, herbal supplements also have been assigned to the ONS PEP weight-of-evidence category "benefi ts balanced with harms." Studies have described potential interactions among herbal agents and chemotherapy and other common drugs, making herbal agents potentially dangerous for use in patients with cancer. Herbal supplements are not recommended for patients receiving chemotherapy unless they consult and receive approval from the oncology team. Oncology clinicians are advised to review a patient's use of herbal agents at regular intervals, dependent on the treatment plan. Review of herbal agent use should be integrated into oncology clinical practice. For more information, refer to the ONS PEP card (see Appendix) and the online PEP resources (www .ons.org/outcomes).
Nonpharmacologic Interventions
All nonpharmacologic interventions for sleep-wake disturbances that have been tested in patients with cancer currently are classifi ed in the "effectiveness not established" category. Interventions for which data currently are insuffi cient or of inadequate quality are included in this category, and it contains reports of pilot or small studies. All but one of the studies (N = 24) presented in the sleep-wake intervention evidence table (see Table 1 ) were published since 2000, which is an indication of the infancy of the research on the symptom. Two A group of three nurses came to be identifi ed as the Sleep Team; one advanced practice nurse, one doctorally prepared nurse researcher with expertise in the topical area, and one staff nurse, who in this case was master's prepared. The team developed the Oncology Nursing Society (ONS) Sleep-Wake Disturbances Putting Evidence Into Practice (PEP) card and Web site resources. The collaboration across skill levels and educational backgrounds provided an opportunity and encouragement for the advanced practice nurse and staff nurse to become familiar with and involved in outcomes research. It also provided an opportunity for translation from research to the bedside by mixing skill levels, points of view, and, in this case, a variety of prior nursing experiences in roles and patient populations.
Using the state-of-the-science sleep-wake disturbances work as a basis for reference, the team developed the ONS PEP resources. The state-ofthe-science group had conducted several computerized literature searches on the major search engines (MEDLINE ® , CINAHL ® , and PsychINFO) during 2004 and early 2005. Key words used for primary and secondary searches included sleep, sleep disturbance, sleep-wake disturbance, cancer, intervention, insomnia, sleep restriction, sleep hygiene, relaxation therapy, massage, and yoga. The searches were rerun in an attempt to identify all pharmacologic and nonpharmacologic intervention studies that examined sleep disturbances or sleep quality outcomes in adults with cancer. As of March 2005, no pharmacologic studies and 20 nonpharmacologic studies were identifi ed. The literature was reviewed again for new articles using the same search technique prior to the initial ONS PEP meeting in June 2005 and again prior to submission of PEP resources in December 2005. Twenty-four studies met inclusion criteria, which were reports in the English language of studies examining pharmacologic or nonpharmacologic interventions for sleep-wake disturbances, measurement of sleep by using either an instrument designed to measure sleep or an item or a subscale from another instrument, scores on the sleep measure reported in the results, and study participants including people diagnosed with cancer at any time point since diagnosis.
The model for synthesis of evidence-based literature described by Rutledge, DePalma, and Cunningham (2004) guided the review process. Phase I included organizing and searching the literature and gathering the original articles. A medical librarian was used to ensure that all literature that met the search criteria was found. Much of this work had been completed prior to the formation of the Sleep Team by those involved with the ONS sleepwake disturbances state-of-the-science conference in 2004. That work is available in an associated article that was published in 2005 . In phase II, the Sleep Team critiqued the selected literature and developed the evidence table for sleep-wake disturbances (see Table 1 ). Information was retrieved from the intervention, sample, setting, study design, measurement, and results categories. All of the current article's authors participated in the process. In phase III, the team classifi ed the level of evidence of the studies using the ONS PEP Classifi cation Schema that had been developed as part of the overall PEP process. Phase IV was the dissemination phase, and this article serves to present and disseminate conclusions and clinical implications of that process to clinical nurses.
Similar to many projects, the present project had inherent diffi culties and problems. One problem in the ONS PEP development was defi ning the final product. The initial PEP teams were the fi rst ones to formulate a vision of the scope of the process and the resources that would be developed. The project took more time and required more revisions than anticipated because of its evolving nature and scope. A second issue was trying to fi t the nursing intervention studies into the classifi cation systems currently in use for evaluating the levels of evidence of medical and nursing research studies (Hadorn, Baker, Hodges, & Hicks, 1996; Ropka & Spencer-Cisek, 2001) . Working collaboratively, the advanced practice nurse, nurse researcher, and staff nurse teams from each of the four outcome groups helped make evidence-based interventions accessible to clinical nurses. This was done by reaching consensus about who the user was and the scope of the project, as well as developing the ONS PEP weight-of-evidence classifi cation model (Gobel, Beck, & O'Leary, 2006) . Sleep improved from baseline to four weeks to eight weeks after intervention. 
The Process of Putting Evidence Into Practice

LEVELS OF EVIDENCE AND COMMENTS
Exercise-PEP Weight-of-Evidence Category: Effectiveness Not Established
publications from the same data sets by two authors were counted as one study for the evidence Results of large randomized, controlled trials are needed to confi rm the mostly positive results from these small, nonrandomized studies. Several issues regarding the strength of evidence of the studies were reviewed. Sleep was a primary outcome variable in only 42% of the studies. The samples represented a variety of cancers, but the groups were relatively small and had a predominance of Caucasian subjects who were undergoing active treatment in outpatient settings. Most of the studies were quasiexperimental designs with no control groups. Six were randomized, controlled trials, although sample sizes usually were fewer than 100. No consistency existed across studies regarding tools used to measure the outcomes, making the results diffi cult to compare. Most of the studies were conducted in the United States or Canada, with a few using a sample of Western Europeans. The development of the knowledge base on this topic will be indicated when results are reported from several large randomized, controlled trials that have used sleep measurements with established psychometric properties and whose primary outcome variable has been sleep-wake disturbances. More information about measurement of sleep-wake disturbances can be found on the ONS Web site at www.ons.org/evidence.
CBTs involve a variety of psychological and behavioral treatments that can be used alone or in combination. They can change negative thought processes, attitudes, and behaviors related to a person's ability to fall asleep, stay asleep, get enough sleep, and function during the day. More than 20 CBTs have been developed since 1985 for use in acute and chronic insomnia; among the most effective interventions are stimulus control, sleep restriction, relaxation therapy, and sleep hygiene . Interventions have been tested in patients with cancer using the following CBTs: NuCare, stimulus control, sleep restriction, relaxation therapy, sleep hygiene, profi le-tailored CBT, and cognitive restructuring strategies. For more information about the strategies, view the ONS PEP resources online at www .ons.org/outcomes). As a group, results show that several sleep disturbance variables have been improved with CBTs, including higher sleep quality , longer duration , and higher sleep effi ciency (Davidson et al.; Quesnel et al.) . demonstrated that the individual sleep promotion plan intervention maintained normal ranges of sleep variables except the number and length of nighttime awakenings.
CTs are a group of diverse medical and healthcare practices and products that presently are not considered to be part of conventional medicine. The following CT interventions have been tested in patients with cancer: aromatherapy, expressive therapy, expressive writing, healing, autogenic training, massage, muscle relaxation, mindfulness-based stress reduction, and yoga. Results indicate that when specifi c CTs were employed, several sleep-wake disturbance variables improved, including higher sleep quality Soden, Vincent, Craske, Lucas, & Ashley, 2004) , shorter latency , longer duration , higher sleep effi ciency (Simeit et al.) , less daytime dysfunction (de Moor et al.) , and use of fewer medications (Cohen et al.; Simeit et al.) . Swedish techniques of therapeutic massage resulted in sleep quality remaining the same but not improving .
Psychoeducation and information interventions include the use of structured education via a variety of media to provide patients with specifi c information regarding treatment and side effects. One randomized, controlled trial, using a single-item measure of sleep, increased sleep duration using an educational informational tape in men receiving radiation for localized prostate cancer . Another randomized, controlled trial, using a modifi ed self-care diary to measure the severity of sleep disturbances, showed no change in sleep disturbances after using informational audiotapes in women with breast cancer undergoing chemotherapy .
Exercise interventions involve any planned, structured, and repetitive bodily movement that is performed with the intent of improving or maintaining one or more components of physical fi tness, performance, or health. Three aerobic, strength, and resistance training exercise interventions have been conducted for the primary purpose of improving exercise tolerance and decreasing fatigue; a secondary outcome was improving sleep. One quasi-experimental study reported that patients in the experimental group who used a self-paced, progressive, homebased exercise program had less diffi culty sleeping . Another quasi-experimental study revealed that self-reported sleep patterns were improved in subjects who met twice per week for exercise and education . A third study found that conducting a home-based aerobic and resistance-training exercise program for patients who were receiving high-dose chemotherapy and peripheral blood stem cell transplantation for multiple myeloma was feasible; the intervention is being tested now in a larger sample using a randomized, controlled trial design . View the original articles that are included in Table 1 , the Appendix, and the online ONS PEP resources to learn more about the interventions designed to improve sleep-wake disturbances in patients with cancer (ONS, 2005 (ONS, , 2006 .
Summary
Sleep-wake disturbances have been identifi ed as common and distressing symptoms in patients with cancer. No evidence-based nursing interventions for sleep-wake disturbances can be given the highest recommendation at this time. The reasons relate primarily to the infancy of research in the topic area and the many gaps in knowledge.
The current study designs frequently are descriptive or quasiexperimental. Few instruments have established psychometric properties in patients with cancer, and they have been used inconsistently. Sleep rarely has been selected as the primary outcome of cancer symptom management studies. When sleep is not the primary outcome, instruments by which sleep and day functioning and sleepiness are measured are more likely to be brief and unidimensional. Because of the inconsistency in selecting instruments to date, few comparisons can be made among results of the studies. The development of the knowledge base on this topic will be indicated when results of several large randomized, controlled trials are reported in which the primary outcome variable is sleep-wake disturbances.
A need also exists to expand samples to include a wider scope of cancer diagnoses, stages of disease, and treatments. Samples of patients with breast cancer and mixed diagnoses have been included most frequently in studies to date. Most studies have examined patients' sleep during active cancer treatment, with fewer examining sleep during long-term follow-up and none examining sleep at the end of life. Studies have been conducted most frequently in the outpatient setting and less often in hospitals and rehabilitation settings in the United States or Canada, with a few in Western Europe.
Nursing educators need to include suffi cient content about sleep to students at the graduate and undergraduate levels (Lee, Landis, et al., 2004) . Educators also need to teach students to develop care plans that use the highest levels of evidence-based interventions for patients with cancer.
Clinical nurses can use the PEP card and online resources to become familiar with several types of interventions that show promise and have shown effi cacy in smaller studies, including CBTs, a variety of CTs, psychoeducational strategies, and exercise techniques. The Clinical Sleep Assessment for Adults and Children (Lee & Ward, 2005) has been selected by the state-of-the-science conference participants as an ideal tool to use to screen for sleep-wake disturbances in the clinical setting . Clinicians can use assessment data to design and implement a tailored intervention to increase patients' ability to fall asleep, stay asleep, and wake up refreshed and without excessive daytime sleepiness. Clinical nurses gradually will become more comfortable teaching patients about interventions to improve sleep in one or more of the categories. The PEP card provides clinical nurses with resources to access current evidence-based interventions for specifi c NSPOs. The recommendations for practice enable nurses to provide high-quality, evidence-based care to patients with cancer experiencing sleepwake disturbances.
Author Contact: Margaretta S. Page, MS, RN, can be reached at pagem@ neurosurg.ucsf.edu, with copy to editor at CJONEditor@ons.org.
Appendix. Putting Evidence Into Practice Card on Sleep-Wake Disturbances What Can Nurses Do to Assist People With Cancer With Sleep-Wake Disturbances?
R E C O M M E N D E D F O R P R AC T I C E
Interventions for which effectiveness has been demonstrated by strong evidence from rigorously designed studies, meta-analyses, or systematic reviews and for which the expectation of harms is small compared to the benefi ts There is no intervention that can be recommended for nursing practice as of 12/1/2005.
L I K E LY TO B E E F F E C T I V E
Interventions for which the evidence is less well established than for those listed under "Recommended for Practice"
There is no intervention that is likely to be effective for nursing practice as of 12/1/05.
B E N E F I T S BA L A N C E D W I T H H A R M S
Interventions for which clinicians and patients should weigh the benefi cial and harmful effects according to individual circumstances and priorities
Pharmacologic
In spite of widespread use, no published meta-analyses or experimental design studies examining the effi cacy of hypnotic drugs in patients with cancer were found. Nurses must systematically evaluate how patients with cancer respond to a pharmacologic intervention, particularly the effi cacy, side effects, and potential interactions with other over-thecounter and prescription medications they are taking. 1, 2 Although the drugs have not been studied in patients with cancer, hypnotics are commonly prescribed for short-term use. Benzodiazepines and nonbenzodiazepine drugs vary in their half-lives. Those with longer half-lives can cause daytime sleepiness and impair functioning; those with shorter half-lives may wear off in the middle of the night. Agents included in the National Cancer Institute's PDQ ® Sleep Disorders Web site 3 that are commonly prescribed but must be individually evaluated for side-effect profi le include • Benzodiazepines: diazepam 5-10 mg, triazolam 0.125-0.5 mg, and clonazepam 0.5-2 mg • Nonbenzodiazepine hypnotics: zolpidem tartrate 5-20 mg, zaleplon 10-20 mg, and eszopiclone 1-3 mg • Other classes of drugs: Tricyclic antidepressants, second-generation antidepressants, antihistamines, chloral derivatives, and neuroleptics are less commonly used but may be considered to improve sleep.
Herbal supplements
No published meta-analyses or experimental design studies were found specifi c to the effi cacy of herbal therapy in patients with cancer. Studies describe potential interactions between herbal agents with chemotherapy and other common drugs, making herbal agents potentially dangerous for use in people with cancer. 4
E F F E C T I V E N E S S N OT E S TA B L I S H E D
Interventions for which insuffi cient data or data of inadequate quality currently exist
Cognitive behavioral therapy
Therapy that involves changing negative thought processes and attitudes about one's ability to fall asleep, stay asleep, get enough sleep, and function during the day 5
Instruct patients in the following stimulus control and sleep restriction techniques.
• Go to bed only when sleepy and at approximately the same time each night. • Get out of bed and go to another room whenever unable to fall asleep; return to bed only when sleepy again. • Use the bedroom for sleep and sex only. • Maintain a regular rising time each day. • Avoid daytime napping. If needed, limit to 30-45 minutes.
Sleep hygiene techniques include behaviors to promote a good night's sleep and optimal functioning the next day. 5 • Use a preferred relaxation technique within two hours of going to bed, such as taking a warm bath or shower, reading, listening to soft music, receiving a massage, etc. • Avoid caffeine after noon; complete dinner three hours before bedtime; do not go to bed hungry. • Replace mattress every 10-12 years and pillows more frequently;
keep the bedroom cool and use light covers; do not watch television in the bedroom, etc.
Two randomized controlled trials and four quasi-experimental studies have tested cognitive-behavioral therapy, primarily with patients with breast cancer and also with patients with a variety of other cancer diagnoses. [6] [7] [8] [9] [10] [11] [12] [13] Results included favorable sleep outcomes, except that the number and length of night awakenings were greater than normal limits.
Complementary therapies, including expressive therapy, expressive writing, healing, autogenic training, massage, muscle relaxation, mindfulness-based stress reduction (MBSR), yoga • Encourage patients to decrease stress by selecting relaxation techniques that suit them, including massage, individual muscle relaxation, meditation, MBSR, yoga, and autogenic training. • Encourage patients to keep a journal in which they document their deepest thoughts and feelings about their illness and treatment. • Encourage patients to decrease stress by focusing on and isolating various muscle groups while moving progressively up and down the body. Encourage focused breathing, with all attention centered on the sensations of breathing, including the rhythm and rise and fall of the chest. • Provide referral to appropriate practitioners as needed.
One randomized controlled trial and two quasi-experimental trials looked at MBSR, a combination therapy of relaxation techniques, meditative techniques, and yoga, in breast cancer, early prostate cancer, and a mixed group of cancer populations and found improved sleep quality with the therapy. [14] [15] [16] [17] Two studies using mixed cancer populations found autogenic training to have favorable sleep outcomes. 18, 19 Patients with lymphoma showed signifi cant decreases in sleep disturbances with Tibetan yoga. 20 Supportive-expressive group therapy intervention resulted in decreased wakeafter-sleep-onset time in patients with breast cancer. 21 One randomized controlled trial with subjects with newly diagnosed stage IV metastatic renal cell cancer showed improvement in four measured areas of sleep disturbance when using expressive writing. 22 One randomized controlled trial with a variety of cancer populations showed a reduction in sleep latency when using progressive muscle relaxation. 23 Patients with a variety of cancer diagnoses showed improvement on self-reported sleep disturbances with the use of healing touch. 24 One study that looked at the use of massage on a group of patients with a variety of cancers undergoing therapy showed unknown benefi t. 25 Education/information • Provide patients with information regarding specifi cs of treatment and expected side effects, including sleep-wake disturbances. • Repeat this information throughout the treatment. • Teach patients basic information about sleep hygiene (see "Cognitive behavioral therapy"). One randomized controlled trial showed favorable sleep outcomes using an informational tape as an educational intervention with men receiving radiation for localized prostate cancer. 26 Another randomized controlled trial using informational audiotapes with women with breast cancer undergoing chemotherapy showed no change in sleep disturbances. 27
Exercise
• Rule out bone metastasis or exercise contraindications. • Have patients complete moderate exercise (e.g., brisk walking [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] minutes four to fi ve times per week) at least three hours before bedtime. • Encourage patients to perform strength and resistance training. Two quasi-experimental studies showed favorable sleep outcomes using aerobic exercise, one with patients with breast cancer and another with patients with a variety of cancers. 28, 29 A third study looking at exercise and sleep in subjects with multiple myeloma was inconclusive because of a high (42%) attrition rate. This content, published by the Oncology Nursing Society (ONS), refl ects a scientifi c literature review. There is no representation nor guarantee that the practices described herein will, if followed, ensure safe and effective patient care. The descriptions refl ect the state of general knowledge and practice in the fi eld as described in the literature as of the date of the scientifi c literature review. The descriptions may not be appropriate for use in all circumstances. Those who use this content should make their own determinations regarding safe and appropriate patient care practices, taking into account the personnel, equipment, and practices available at their healthcare facility. ONS does not endorse the practices described herein. The editors and publisher cannot be held responsible for any liability incurred as a consequence of the use or application of any of the contents of this appendix.
